Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Novel health care strategies for melanoma in children, adolescents and young adults

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Partner registration status (se abrirá en una nueva ventana)

List of partners identified in level of involvement.

Policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting 1 (se abrirá en una nueva ventana)

Report on policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting

Immuno-Ped initiation package (se abrirá en una nueva ventana)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.

Standardized protocols for tumor tissue processing (se abrirá en una nueva ventana)

Document detailing the standardized protocols for tumor tissue processing (inclusion, orientation of the sample, sectioning, etc)

Dissemination & communication plan 1 (se abrirá en una nueva ventana)

Document describing the dissemination and communication plan

Project Management Plan (se abrirá en una nueva ventana)

Document describing the management plan for MELCAYA project

Plan for ethic-legal monitoring & ethical submissions 1 (se abrirá en una nueva ventana)

Document detailing the plan for ethic-legal monitoring & ethical submissions

Common work plan for scientific collaboration under the ‘Understanding’ cluster (se abrirá en una nueva ventana)

Report on the common work plan for scientific collaboration under the ‘Understanding’ cluster

NevustoMel initiation package (se abrirá en una nueva ventana)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.

Patient engagement plan (se abrirá en una nueva ventana)

Detailed plan for patient engagement

AI-MEL initiation package (se abrirá en una nueva ventana)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.AI-MEL study protocol will include information about how humans will maintain meaningful control over the decision-making process for the use of the prediction and diagnostic tool to be developed in the project.

Plan for ethic-legal monitoring & ethical submissions 2 (se abrirá en una nueva ventana)

Document detailing the plan for ethic-legal monitoring & ethical submissions

Conclusions of common annual meeting of the ‘Understanding’ cluster 1 (se abrirá en una nueva ventana)

Report on the conclusions of common annual meeting of the ‘Understanding’ cluster

Precis-mel initiation package (se abrirá en una nueva ventana)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.The study protocol will include information about how humans will maintain meaningful control over the decision-making process for the use of the prediction and diagnostic tool to be developed in the project. No further deliverables will be required.

Quality Assurance and Risk Management Plan (se abrirá en una nueva ventana)

Document detailing the Quality Assurance and Risk Management Plan

ExpoMel initiation package (se abrirá en una nueva ventana)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.

Mol-Mel initiation package (se abrirá en una nueva ventana)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.

Common video and/or a common cluster brochure (se abrirá en una nueva ventana)

Video and/or common cluster brochure of the projects included in the Mission Cancer Cluster 'Understanding'.

Project Website (se abrirá en una nueva ventana)

MELCAYA webpage with public and private domains

Online and media presence 1 (se abrirá en una nueva ventana)

Document with the summary of all on line MELCAYA post, citations and interactions

Data Management Plan 1 (se abrirá en una nueva ventana)

Document detailing the Data Management PlanThe preparation of the Data Management Plan will include a common chapter onthe ‘Understanding’ cluster. The aim of the chapter is to addresscommonalities in data standards, data validation, data protection andfostering data exchange, in particular when it comes to sharing project datawith a future federated UNCAN.eu data platform. Therefore, interactions areenvisaged with the 4.UNCAN.eu (http://uncaninitiative.eu/) coordination andsupport action which is preparing a blueprint for UNCAN.eu.

Publicaciones

Braf-mutant Schwann cells divert to a repair phenotype to induce congenital demyelinating neuropathy (se abrirá en una nueva ventana)

Autores: Elise Marechal, Patrice Quintana, Daniel Aldea, Grégoire Mondielli, Nathalie Bernard-Marissal, Mathias Moreno, Valérie Delague, Lauren A. Weiss, Anne Barlier, Heather C. Etchevers
Publicado en: bioRxiv, 2024, ISSN 1531-6386
Editor: bioRxiv
DOI: 10.1101/2024.04.24.590951

Buscando datos de OpenAIRE...

Se ha producido un error en la búsqueda de datos de OpenAIRE

No hay resultados disponibles

Mi folleto 0 0